← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LLC · Approved 2017-03-23

Drug application

FDA Application #

ANDA204380

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

Dapsone

Active ingredients

DAPSONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS LLC

First approval

2017-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown